← Open Payments lookup

VALENTINA STERLIN: Open Payments

NPI 1932561008 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$7,995 in 134 payments from 30 companies in 2025. Trend: 2023 $3,659 · 2024 $2,818 · 2025 $7,995

Food & beverage: $2,545Speaker / faculty: $2,200Travel & lodging: $1,883Long term medical supply or device loan: $1,098Education: $269
CompanyPaymentsAmount
Stemline Therapeutics Inc.8$4,232
Novartis Pharmaceuticals Corporation35$1,484
Janssen Biotech, Inc.17$440
E.R. Squibb & Sons, L.L.C.12$229
AstraZeneca Pharmaceuticals LP6$226
Gilead Sciences, Inc.5$188
SOBI, INC6$167
BeOne Medicines USA, Inc.4$103
GlaxoSmithKline, LLC.3$80
PharmaEssentia USA Corporation4$79

Products named: Orserdu, KISQALI, Trodelvy, RYBREVANT, DARZALEX, LUTATHERA, REBLOZYL, BRUKINSA.

Industry payments across NY — which companies pay providers there.